Bausch Health Companies Inc.

BHCNYSEHealthcare● Active

$5.37

+$0.11(+2.09%)

Market Cap$2.0B

P/E Ratio—

52W High$8.69

52W Low$4.61

Avg Volume1.7M

Open$5.27

Beta0.41

Free Cash Flow Financials Revenue

Bausch Health Companies Inc. (BHC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BHC · free cash flow · updated Jun 8, 2026

Core FCF metrics

BHC · FCF · TTM · margin & CAGR

Free cash flow was $1.00B for FY2025 (fiscal year ending 2025-12-31), down 20.4% year-over-year The FCF margin was 9.6%. Five-year CAGR stands at +4.6%.

FY2025 Free Cash Flow$1.00B▼ -20.4% YoY

Trailing 12M (TTM)$989.5Mtrailing 4 quarters sum

FCF Margin9.6%$1.00B ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+4.6%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BHC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.40B(397M)$1.00B▼ 20.4%9.6%

FY2024$1.60B(337M)$1.26B▲ +65.8%13.1%

FY2023$1.03B(272M)$760.0M▲ +176.3%8.7%

FY2022−$728.0M(268M)−$996.0M▼ 187.1%-12.3%

FY2021$1.43B(283M)$1.14B▲ +42.5%13.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BHC · P/FCF · FCF yield · FCF per share

Bausch Health Companies Inc. (BHC) trades at a FCF yield of 49.34% and a price-to-free-cash-flow ratio of 2.0x. FCF per share stands at $2.67, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

49.34%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.67

TTM FCF ÷ Shares Outstanding

Price / FCF

x2.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

BHC · cash flow statement · operating / investing / financing

For FY2025, Bausch Health Companies Inc. generated $1.40B in operating cash flow and spent 397M in capital expenditures, yielding $1.00B in free cash flow.

Operating Activities

+$1.40B

Cash from core business operations

2025-12-31

Investing Activities

−$595.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$742.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.40B) − |CapEx| (397M) = FCF ($1.00B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

BHC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Bausch Health Companies Inc.YOU

BHC

$1.00B-20.4%9.6%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Bausch Health Companies Inc. (BHC) reported free cash flow of $1.00B for FY2025 (fiscal year ending 2025-12-31), down 20.4% year-over-year. The FCF margin was 9.6%.

Based on available data, Bausch Health Companies Inc. has maintained positive free cash flow for at least 14 fiscal year(s). FCF peaked at $1.95B in FY2017. The 5-year CAGR stands at +4.6%.

Bausch Health Companies Inc.'s FCF yield is 49.34% and price-to-FCF ratio is 2.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BHC free cash flow · 8 questions

Bausch Health Companies Inc. free cash flow was $1.00B for FY2025, down 20.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $989.5M.

BHC free cash flowBHC FCFBHC FCF 2025BHC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Bausch Health Companies Inc. · Bausch Health Companies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026